Resilience (Healthtech) Stock
HealthTechLooking to sell Resilience (Healthtech) stock or options?
Resilience (Healthtech) aims to revolutionize medicine production through its biopharmaceutical manufacturing services. The company provides tailored manufacturing solutions to meet the distinct needs of biopharmaceuticals throughout various drug development stages, from pre-clinical trials to commercial production. Resilience (Healthtech) ensures its clients receive customized, scalable processes and facilities designed for complex and innovative medicines.
Pfizer Ventures, Alternative Investment Management, Omega Funds, Rsquared, AIM13 CV Partners, Koch Disruptive Technologies, Archery Venture Partners, Catalio Capital Management, Echo Investment Capital, Global Health Investment Corporation.